Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor

By Josh Enomoto, InvestorPlace Contributor

While getting kicked off an exchange typically signals about the biggest warning sign you can possibly receive, a (somewhat) rational argument exists for delisted stocks…

7 Compelling Stocks to Buy That are Sitting at 52-Week Lows

By Josh Enomoto, InvestorPlace Contributor

In arguably most circumstances, when you see stocks at 52-week lows, you should avoid them. Based on prevailing market theory, equity valuations culminate from the…

Black Friday Winners: 7 Retail Stocks Set for Post-Holiday Gains

By Josh Enomoto, InvestorPlace Contributor

Given so much talk about stubbornly elevated inflation and soaring borrowing costs, it’s not surprising that retail stocks incurred much skepticism throughout this year. However,…

Twilio Layoffs 2023: What to Know About the Latest TWLO Job Cuts

By Josh Enomoto, InvestorPlace Contributor

Although the third round of Twilio layoffs may buy some time, activist investors of TWLO stock may be seeking bigger changes.

Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?

By Josh Enomoto, InvestorPlace Contributor

Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.

Load More